ArticlePakistan journal of medical sciences2026
Maternal and fetal outcomes in pregnant women with liver disease.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine the maternal and fetal outcomes among pregnant females with liver disease. Methodology: This prospective observational study was performed at the department of obstetrics & gynecology, Nishtar Hospital Multan, Pakistan, during August 2024 to July 2025. Pregnant females aged 20-40 years with gestational age ≥ 28 weeks, regardless of their parity or gravidity status, with liver disease, and planned to undergo delivery were analyzed. Demographic, clinical and laboratory parameters were documented. Clinical presentation, causes of liver disease, and details about the treatment were recorded. Fetal and maternal outcomes in terms of survival or death were noted. Results: Among the 136 women, the median age, gestational age, and BMI were 29.50 (26.00-35.00) years, 36.00 (34.00-38.00) weeks, and 27.65 (25.05-30-98) kg/m Conclusion: The findings suggest a possible association of acute fatty liver disease with adverse maternal and fetal outcomes. Although the observed mortality rates were relatively low, careful monitoring and appropriate management of pregnant women with liver disease remain important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.